MedPath

An observational study to determine the relationship between blood concentrations of Nintedanib and the safety of the drug in the real world.

Not Applicable
Recruiting
Conditions
interstitial pneumonia
Registration Number
JPRN-UMIN000052260
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Individuals deemed unsuitable by the principal investigator and co-investigators. 2. Those who were unable to provide consent for this research.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The association between blood levels of Nintedanib and the occurrence of adverse effects.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath